GLP-1 analogs are clinically effective in treating type 2 diabetes and obesity4, but they have been reported to be associated with adverse events, including nausea, vomiting, diarrhea, and gallbladder issues4–6. The gene discussed is GCG; the disease is type 2 diabetes mellitus.